Recent News

• 06.06.2025 - ProPhase Labs Announces Formation of Clinical Science Advisory Board to Accelerate Commercialization of BE-SmartTM Esophageal Disease Diagnostic Platform
• 06.06.2025 - ProPhase Labs Announces Formation of Clinical Science Advisory Board to Accelerate Commercialization of BE-SmartTM Esophageal Disease Diagnostic Platform
• 05.20.2025 - ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2025
• 05.20.2025 - ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2025
• 05.13.2025 - ProPhase Labs Inc. to Present First Quarter 2025 Financial Results on May 20, 2025
• 05.13.2025 - ProPhase Labs Inc. to Present First Quarter 2025 Financial Results on May 20, 2025
• 03.31.2025 - ProPhase Labs, Inc. Announces Financial Results for the Year Ended December 31, 2024
• 03.31.2025 - ProPhase Labs, Inc. Announces Financial Results for the Year Ended December 31, 2024
• 03.27.2025 - ProPhase Labs Inc. to Present 2024 Year End Financial Results on March 31, 2025
• 03.27.2025 - ProPhase Labs Inc. to Present 2024 Year End Financial Results on March 31, 2025

Recent Filings

• 05.20.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.20.2025 - EX-99.1 EX-99.1
• 05.20.2025 - 8-K Current report
• 05.16.2025 - NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB
• 04.30.2025 - 10-K/A Annual report [Section 13 and 15(d), not S-K Item 405]
• 04.01.2025 - NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
• 04.01.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.31.2025 - 8-K Current report
• 03.31.2025 - EX-99.1 EX-99.1
• 03.28.2025 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments